Skip to main content
Premium Trial:

Request an Annual Quote

Patrick Zenner, Alan Nies, Robert Friedman, Terri Lomax, Douglas Falkner, Larry Felser, John Tyson, John Guckenheimer, Christoph Lengauer, Mike Shuler

Premium

Patrick Zenner has joined the board of directors of Exact Sciences of Maynard, Mass., the applied genomics company said last week. Zenner was president and CEO of

Hoffman-LaRoche

before retiring in 2001. He is member of the board of directors for Curagen, Genta, Praecis Pharmaceuticals, and Xoma. Zenner holds an MBA from Fairleigh Dickinson University and a BS in business administration from Creighton University.

 

Alan Nies has joined the medical advisory board of Lexicon Genetics of The Woodlands, Texas, the company said last week. Nies is senior vice president, clinical sciences, at Merck. He holds an MD from Harvard Medical School and a BS from Stanford University.

 

Robert Friedman will become vice president for environment and energy policy at the Center for the Advancement of Genomics and the Institute for Biological Energy Alternatives. Friedman leaves the Heinz Center, where he was a vice president.

 

Terri Lomax, a professor of botany at Oregon State University, has been named director of NASA’s fundamental space biology division for a term to cover from two to four years. Lomax will keep her position at Oregon State, where she is director of the university’s program for the analysis of biotechnology issues.

 

Douglas Falkner has been named managing director of East Coast operations for Los Angeles-based Applied DNA Sciences and will be located in the company’s new office in Henderson, NC. Falkner holds an MBA from the University of Southern California.

 

Larry Felser has been named director of systems and software development for Gene Network Sciences of Ithaca, NY. The company expanded its scientific advisory board, adding: John Tyson, professor of molecular cell biology at Virginia Tech; John Guckenheimer, a Cornell mathematics professor; Christoph Lengauer, assistant professor of oncology at Johns Hopkins University; and Mike Shuler, a Cornell professor of chemical engineering.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.